Two-year efficacy and safety of simvastatin 80 mg in familial hypercholesterolemia (the Examination of Probands and Relatives in Statin Studies With Familial Hypercholesterolemia [ExPRESS FH]).
de Sauvage Nolting
Pernette R W
PR
Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands. p.desauvagenolting@amc.uva.nl
Buirma
Rudolf J A
RJ
Hutten
Barbara A
BA
Kastelein
John J P
JJ
D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D001053:Apolipoproteins / Q000097:blood / Q000187:drug effects; D003402:Creatine Kinase / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D008074:Lipoproteins / Q000097:blood / Q000187:drug effects; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000139:chemically induced; D019821:Simvastatin / Q000008:administration & dosage* / Q000009:adverse effects; D013997:Time Factors; D000637:Transaminases / Q000187:drug effects; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D001053:Apolipoproteins; D008074:Lipoproteins; D014280:Triglycerides; D019821:Simvastatin; D000637:Transaminases; D003402:Creatine Kinase